Apixaban is a new drug that acts by :
Rivaroxaban and Apixaban are newer oral anticoagulants that act by inhibiting factor Xa.
Newer oral anticoagulants that are currently being asked in the exams are:

Dabigatran (Direct thrombin inhibitor)
Rivaroxaban
Apixaban
Inhibiting TNF alpha
Inhibiting coagulation factor Xa
Inhibiting platelet aggregation
Activating plasminogen